Marinus Pharmaceuticals, Inc. | ||||
NGM : MRNS || Location: United States | ||||
$1.4-0.01 (-1.06%) |
0.49 M | 1.38 - 1.44 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
April 15, 2024 | 4.515 M |
March 28, 2024 | 3.475 M |
March 15, 2024 | 3.573 M |
Feb. 29, 2024 | 3.427 M |
Feb. 15, 2024 | 3.570 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.64 | -0.74 | -16.46% |
09/30/2023 | -0.67 | -0.61 | 9.48% |
06/30/2023 | -0.73 | -0.61 | 16.56% |
03/31/2023 | -0.74 | -0.67 | 9.13% |
12/31/2022 | -0.71 | -0.76 | -6.95% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 54.931M | Shares Float | 38.283M |
Short Float | 4.515M | Market Cap | 78.00M |
Institution ownership | 0.00% | Insider ownership | 0.966% |
Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
Trailing EPS | -2.63 | Forward EPS | -1.29 |